About The Conference

The International Conference on Medical Science Technology is back!!! Our second edition of the conference, ICMST 2018 will be held on the 14th and 15th November 2018 at Tenera Hotel, Bangi, Malaysia. We welcome and hope to see all of you there!!

The conference will feature globally renowned speakers and delegates from academia, research centers and industry to share insights and disseminate research findings specifically related to medical science technology and environmental health. The conference will provide an international platform for the exchange of knowledge and expertise in relevant fields and promote exploration of potential collaboration for future research.

The conference theme for this year’s edition is:

EMPOWERING HEALTHCARE TRANSFORMATION via TRANSDISCIPLINARY RESEARCH

The four sub-themes that will be weaved through by plenary talk, oral and poster presentations are:


Public Health
Environmental Health
Occupational Safety & Health
Food & Nutritional Science
Sports Science
Mental Health
Health Wellbeing

Clinical Laboratory Diagnostic
Chemical Pathology
Microbiology
Hematology
Transfusion Science & Blood Banking
Histopathology
Cytology

Biomedical Sciences
Biochemistry
Immunology
Pharmacology & Toxicology
Molecular Biology
Physiology
Infectious Diseases
Non-Communicable Diseases

Healthcare Innovation
Biomedical Engineering
Digital Health
Alternative & Complementary Medicine
Wellness & Beauty
Healthcare Entrepreneurship
Food Technology

 

Confirmed Speakers:

Professor Dr. Maurice is currently  Emeritus Professor of Experimental Cell Biology. He obtained his first degree (BSc Pharmacology) from the University College London (UCL) followed by a PhD Degree from the Department of Pharmacology, also from UCL undertaking a project on Ca2+ in mast cell secretion. Prof. Dr. Maurice’s current research interest is within the Division of Infection and Immunity and is focused on neutrophil behaviour and signalling at the individual cell level. He established the Neutrophil Signalling Group within Cardiff University Medical School with the aim of using novel techniques to understand and influence the activity of these cells which are important in inflammatory diseases. His research group has received fundings from MRC, Wellcome Trust, BBSRC, Arthritis and Research Campaign (ARC), BHF, National Research Network, Cystic Fibrosis Trust and others. He has served as the honorary secretary of the Royal Microscopical Society Committee (Cell Biology) and also the Cell Biology Theme committee of the Biochemical Society.

  • Assoc. Prof. Dr. Rukman Awang Hamat, Universiti Putra Malaysia

Dr. Rukman Awang Hamat is currently an Associate professor in the Department of Medical Microbiology and Parasitology at the Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Malaysia. He completed his MBBS  at University of Malaya in 1996 and Master of Pathology at Universiti Kebangsaan Malaysia in 2006. Dr. Rukman Awang Hamat’s Area of Specialization includes Medical Microbiology, Infectious Diseases, Vaccine-Preventable Diseases, Clinical Parasitology and Tropical Health.

  • Assoc Prof. Dr. Azman Seeni, Universiti Sains Malaysia

Dr. Azman Seeni is an Associate Professor in Molecular Toxico-Pathology at Advanced Medical and Dental Institute (AMDI), Universiti Sains Malaysia. He obtained his Diploma in Medical Laboratory Technology and Bachelor of Applied Science (Biotechnology) from Universiti Sains Malaysia, followed by a Master’s degree in Medical Sciences (Pathology) from Universiti Kebangsaan Malaysia and subsequently a PhD from Nagoya City University, Japan in Molecular Toxico-Pathology. He has over 14 years experience in Cancer Research and published numerous papers with High Impact Factor. He has supervised more than 20 postgraduate students in cancer research and biomaterial products. Dr. Azman has won many local and international prestigious awards such as the American Association Cancer Research Travel Grant Award 2009, Double Gold Award at the British Invention Show 2011 and obtained one patent on chemopreventive agent. Recently, he has focused his research work on cancer chemoprevention agent derived from natural flora and fauna.